Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

FRESENIUS MEDICAL CARE AG & CO. KGAA

(FME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Neutral rating from JP Morgan

05/04/2021 | 07:43am EDT

Initially Neutral on the company, JP Morgan's analyst David Adlington maintained his recommendation. The target price is unchanged at EUR 52.40.


ę MarketScreener with dpa-AFX Analyser 2021
All news about FRESENIUS MEDICAL CARE AG & CO. KGAA
10:45aFRESENIUS SEá : Credit Suisse sticks Neutral
MD
10:22aFRESENIUS MEDICAL CAREá : Credit Suisse Raises Price Target on Fresenius Medical..
MT
06:21aFMC FRESENIUS MEDICAL CARE AG & CO K : Credit Suisse gives a Neutral rating
MD
05/07FRESENIUS SEá : Deutsche Bank sticks Neutral
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Deutsche Bank sticks Neutral
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Gets a Buy rating from Berenberg
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Receives a Buy rating from UBS
MD
05/07FRESENIUS SEá : Gets a Neutral rating from UBS
MD
05/07FMC FRESENIUS MEDICAL CARE AG & CO K : Kepler Cheuvreux gives a Neutral rating
MD
05/06FRESENIUS MEDICAL CARE AG & CO. KGAA : Release according to Article 50 of the Wp..
EQ
More news
Financials (USD)
Sales 2021 21 582 M - -
Net income 2021 1 350 M - -
Net Debt 2021 14 086 M - -
P/E ratio 2021 17,2x
Yield 2021 1,77%
Capitalization 23 074 M 23 116 M -
EV / Sales 2021 1,72x
EV / Sales 2022 1,61x
Nbr of Employees 125 364
Free-Float 63,7%
Chart FRESENIUS MEDICAL CARE AG & CO. KGAA
Duration : Period :
Fresenius Medical Care AG & Co. KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FRESENIUS MEDICAL CARE AG & CO. KGAA
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 21
Average target price 81,36 $
Last Close Price 78,78 $
Spread / Highest target 24,3%
Spread / Average Target 3,27%
Spread / Lowest Target -33,8%
EPS Revisions
Managers and Directors
NameTitle
Rice Powell Chief Executive Officer
Helen Giza Chief Financial Officer
Dieter Schenk Chairman-Supervisory Board
Olaf Schermeier CEO-Global Research & Development
Franklin W. Maddux Global Chief Medical Officer
Sector and Competitors